BANISH

Active Ingredients

Indications

Dyspepsia, Zollinger-ellison syndrome, Pancreatic insufficiency, Duodenal ulcer and gastric ulcer, Recurrent and stomal ulceration, Oesophageal reflux disease, Upper abdominal pain, Gastrointestinal hemorrhage, Reduce malabsorption and fluid loss in short bowel syndrome.

Active Ingredients

Indications

Peptic ulcer, Reflux oesophagitis, Dyspepsia, Duodenal ulcer, Gastritis, Zollinger-ellison syndrome, Benign gastric ulcer, Heart burn, GI bleeding, Aspiration prophylaxis, Pancreatic insufficiency, Esophagitis, Stress ulcers prevention, Mendelsons syndrome prophylaxis, NSAID-induced ulcer prophylaxis.